Comparison of venom from wild and long-term captive Gloydius caucasicus and the neutralization capacity of antivenom produced in rabbits immunized with captive venom

• Main Authors: Fatemeh Rasoulinasab, Masoumeh Rasoulinasab, Delavar Shahbazzadeh, Atefeh Asadi, Mohammad Kaboli
• Format: Article
• Language: English
• Published: Elsevier 2020-12-01
• Series: Heliyon
• Subjects: Gloydius caucasicus; Captive; Venom; Antivenom; Toxicological activity; Proteomics
• Online Access: http://www.sciencedirect.com/science/article/pii/S2405844020325603

Gloydius caucasicus (NIKOLSKY, 1916) is a member of the Viperidae family in Iran.Comprehensive understanding of the toxigenic characteristics of snake venom is important for clinical monitoring of snakebite patients and effective therapy. We compared the toxic activities of venoms and the neutralization capacity of antivenoms produced with venoms from wild adult (WA) with long-term captive adult (LCA) of G. caucasicus in order to obtain more effective antivenom from LCA in therapy, and subsequently protect G. caucasicus from overharvesting for its venom, which poses a real threat of extinction for the species. Our results showed that LD50 of WA and LCA were 16.8 μg/dose and 17.7 μg/dose, respectively. Lower hemorrhagic and necrotic (p ≥ 0.05), and higher coagulative and edematogenic activities (p ≤ 0.05) were observed in WA compared with LCA venom. Also, captive-born neonates exhibited weaker toxic activities compared with captive adult snakes, which could be an age-related difference. Study data illustrated that effective capacity of LCA antivenom to neutralize the toxic activities of WA viper venom. According to the results, about 0.4–4 μl of LCA antivenom is required to neutralize the toxic activities of 1 μg of WA venom, indicating its efficacy in treatment of snakebites in humans. On this basis, it is recommended that capture of wild snakes for their venom be discontinued to reduce their future extinction risk.